Merck to Use Roche AmpliChip p53 Test in Clinical Trials

Roche Molecular Systems will provide Merck Sharp & Dohme with access to its investigational AmpliChip p53 test, which combines Roche's PCR technology with Affymetrix's high-density microarray technology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.